Evidence map›Paper›PMID 42199361›Full record

ArticleCurrent research in microbial sciences2026

Seokcheon Song, Myeonghwan Han, Kwanwoo Moon, Haeseong Lee, Sungchan Ha, Juseok Seo, Seungki Lee, Soyong Jang, Sang Kyun Lim, Nayoung Kim and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current research in microbial sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Seokcheon SongDepartment of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea.
Myeonghwan HanKoBioLabs, Inc., Seoul, Republic of Korea.
Kwanwoo MoonKoBioLabs, Inc., Seoul, Republic of Korea.
Haeseong LeeKoBioLabs, Inc., Seoul, Republic of Korea.
Sungchan HaDepartment of Health Science and Technology, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea.
Juseok SeoR&D Division, Celltrion, Inc., Incheon, Republic of Korea.
Seungki LeeR&D Division, Celltrion, Inc., Incheon, Republic of Korea.
Soyong JangR&D Division, Celltrion, Inc., Incheon, Republic of Korea.
Sang Kyun LimKoBioLabs, Inc., Seoul, Republic of Korea.
Nayoung KimDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
GwangPyo KoDepartment of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Irritable bowel syndrome with diarrhea (IBS-D) is a prevalent disorder that significantly impairs quality of life, yet therapeutic advances remain limited. Serotonin dysregulation, primarily driven by enterochromaffin cells in the intestinal epithelium, is central to IBS-D pathogenesis. We hypothesized that targeted modulation of enterochromaffin cell activity through microbiome-based interventions could provide a novel treatment approach. Here, we screened 128

Indexed as

Bifidobacterium stercorisHost microbe interactionInterferon-βIrritable bowel syndrome with diarrhea

Identifiers

PMID42199361
PMCPMC13200085

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.